Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinli Yang

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Thoracic Cancer|July 21, 2018
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitorsZhansheng Jiang, Yu Zhang, Yinli Yang, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2020
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancerYinli Yang, Ling Li, Zhansheng Jiang, et al.
International Immunopharmacology|June 25, 2016
Hepatitis B virus antigens impair NK cell functionYinli Yang, Qiuju Han, Cai Zhang, et al.
Journal of Leukocyte Biology|May 28, 2019
STAT3 directly regulates NKp46 transcription in NK cells of HBeAg-negative CHB patientsBingqing Zheng, Yinli Yang, Qiuju Han, et al.
Cancer Biology & Therapy|March 3, 2016
Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinomaYinli Yang, Bingqing Zheng, Qiuju Han, et al.
Cancer Gene Therapy|June 14, 2020
Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinomaYinli Yang, Cong Wang, Haiyan Sun, et al.
Cellular & Molecular Immunology|May 31, 2016
Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunctionYinli Yang, Qiuju Han, Zhaohua Hou, et al.
Translational Oncology|January 19, 2025
Anlotinib induced ferroptosis through the p53/xCT/GPX4 pathway in non-small cell lung cancerZhansheng Jiang, Xinge Sun, Yuan Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2017
Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immuneZhansheng Jiang, Yanfang Yang, Yinli Yang, et al.
Frontiers in Oncology|April 27, 2019
Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor PrognosisKaiyuan Wang, Yu Zheng, Yinli Yang, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Thoracic Cancer|July 21, 2018
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitorsZhansheng Jiang, Yu Zhang, Yinli Yang, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2020
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancerYinli Yang, Ling Li, Zhansheng Jiang, et al.
International Immunopharmacology|June 25, 2016
Hepatitis B virus antigens impair NK cell functionYinli Yang, Qiuju Han, Cai Zhang, et al.
Journal of Leukocyte Biology|May 28, 2019
STAT3 directly regulates NKp46 transcription in NK cells of HBeAg-negative CHB patientsBingqing Zheng, Yinli Yang, Qiuju Han, et al.
Cancer Biology & Therapy|March 3, 2016
Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinomaYinli Yang, Bingqing Zheng, Qiuju Han, et al.
Cancer Gene Therapy|June 14, 2020
Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinomaYinli Yang, Cong Wang, Haiyan Sun, et al.
Cellular & Molecular Immunology|May 31, 2016
Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunctionYinli Yang, Qiuju Han, Zhaohua Hou, et al.
Translational Oncology|January 19, 2025
Anlotinib induced ferroptosis through the p53/xCT/GPX4 pathway in non-small cell lung cancerZhansheng Jiang, Xinge Sun, Yuan Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 15, 2017
Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immuneZhansheng Jiang, Yanfang Yang, Yinli Yang, et al.
Frontiers in Oncology|April 27, 2019
Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor PrognosisKaiyuan Wang, Yu Zheng, Yinli Yang, et al.
Pageof 2